its subsidiaries financial statement for 1st quarter ended as of March 31, 2017, which details are as following; Results Q1/2017 Q1/2016 Increase (Decrease) Million Baht Million Baht Million Baht
machines in the existing hemodialysis unit within the Statement of Financial Position – Consolidated (Million Baht) As at Increase (Decrease) % March 31, 2019 December 31, 2018 Assets 980.31 954.82 25.49
amortization 29.44 26.56 2.89 11% EBIT 30.85 27.19 3.66 13% Finance cost -5.87 -2.27 3.60 158% Income tax expenses -6.68 -3.90 2.78 71% Net income for period 18.30 21.02 -2.72 -13% Earnings per share (THB) 0.06
tax expenses -5.80 -4.89 0.91 19% Net income for period 24.74 23.17 1.57 7% Earnings per share (THB) 0.08 0.08 0.00 0% FY 2018 FY 2017 YoY change YoY % change Unit: Million Thai Baht (THB) Sales and
decrease by 75.88 million Baht or 2.47% compared to same period of 2017) due to the declining in raw water sales volume and net profit attributable to Equity holders of the parent company was 881.03 million
% Finance cost -5.95 -0.92 5.03 548% Income tax expenses -2.67 -0.94 1.73 185% Net income for period 13.66 10.49 3.17 30% Earnings per share (THB) 0.05 0.03 0.02 59% FY 2018 FY 2017 YoY change YoY % change
% Income tax expenses -2.79 -0.72 2.07 288% Net income for period 1.80 0.01 1.79 17900% Earnings per share (THB) 0.01 0.00 0.01 17900% FY 2020 FY 2019 YoY change YoY % change Unit: Million Thai Baht (THB
DCORP 011/2019 February 27, 2019 Subject: Report on the overall operation of the year 2018 ended December 31, 2018 and the decrease in the overall operation more than 20 percent Attention: President Stock
asset base in the Americas 21-Mar-18 (Signed: 21-May-18) 2020E (start-up) Avgol Enhances IVL’s HVA portfolio and market share in the personal hygiene segment Accelerates IVL’s global expansion and
Operating Profit Margin 18.0% 19.2% Other income 115.8 109.5 6.3 5.8 Share of profit of investment in associate 2.4 2.5 (0.1) (6.8) Profit before tax expense 1,714.8 1,659.1 55.7 3.4 Profit before tax expense